Search
The WasteWatcherBeware the Words Investment and Free
When government officials talk about “investment” and “free” programs, taxpayers need to hang onto their wallets.
The WasteWatcherPelosi’s Healthcare Nightmare Is Coming Back
Speaker Pelosi's (D-Calif.) 2019 drug pricing bill was introduced again, with all the horribles it had before but more dangerous.
The WasteWatcherSpending Trillions More Is Ahead for Taxpayers
Taxpayers need to buckle up and hang on because even more trillion-dollar spending is ahead.
The WasteWatcherBiden’s Infrastructure Bill Takes Spending Way Off Track
The American Jobs Act contains hundreds of billions of dollars for non-traditional infrastructure projects.
Op-Eds340B Drug Discount Program Should Be on GAO’s High-Risk List
RCH: Nothing has been done to reform 340B and stop hospitals and for-profit pharmacies from enriching themselves.
The WasteWatcherBiden’s COVID-19 Doom and Gloom Team Is Harmful to Recovering from Pandemic
As Americans are beginning to see light at the end of pandemic tunnel, Biden's Covid 19 Team gives gloomy forecast.
The WasteWatcherBernie is Back with More Bad Bills
Sen. Bernie Sanders is at it again with more big government legislation that will hurt pharmaceutical innovation.
The WasteWatcherCDC Guidelines Fail to Quickly Get Students Back into Classrooms
More evidence that children are not at significant risk for COVID-19 and schools are safe for in-school teaching.
The WasteWatcherCDC Guidance Criticized for Being Too Restrained
On Monday, the Centers for Disease Control and Prevention released new guidance for fully vaccinated people.
The WasteWatcher"Normal" is Likely Coming Sooner than Anticipated
Expressions of a desire to move on after a year into the pandemic are quite reasonable and more are taking action doing that.
The WasteWatcherBiden's Budget Busting Boondoggle
The House will soon vote on President Biden's $1.9 trillion COVID-19 relief bill, the American Rescue Plan Act of 2021.
The WasteWatcherDueling Agencies - Part 2?
The CDC should not confuse what the FDA has determined regarding tobacco harm reduction products.
